NLRP3 inflammasome is upregulated after myocardial infarction, atherosclerosis, ischemic heart disease, diabetic cardiomyopathy, chronic heart failure, and hypertension, and recently, NLRP3 and IL‐1β have also been proposed as new cardiovascular risk biomarkers (Bullón et al., 2017; Liu, Zeng, Li, Mehta, & Wang, 2017). The gene discussed is NLRP3; the disease is congestive heart failure.